News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104
Field Trip Health
Cybin to Present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13th
Cybin Inc.
Algernon Pharmaceuticals Announces Appointment of Harry Bloomfield, QC. as a New Board Director and Chairman
Algernon Pharmaceuticals
Dr. Corey Hilmas | Chief Regulatory Officer, KGK Science
Wellbeing Digital Sciences
Ketamine One Signs LOI for Two Ketamine Infusion Clinics in Texas
Wellbeing Digital Sciences
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
NeonMind Biosciences Inc.
PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year Ended May 31, 2021
Revive Therapeutics
Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial
Mydecine Innovations Group
Filament Health Shares to Commence Trading on the OTC Market
Filament Health
Nova Mentis Expands Psilocybin Research Program Targets Obesity and Diabetes
Nova Mentis Life Science
Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose
Algernon Pharmaceuticals
Christopher J. Moreau | Chief Executive Officer, Algernon Pharmaceuticals
Algernon Pharmaceuticals
MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes
Mind Medicine (MindMed)
Filament Health Files 20th Patent Application Including Three International PCT Applications
Filament Health
Ketamine One to Deploy Cognetivity’s Integrated Cognitive Assessment Tool
Wellbeing Digital Sciences
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.